Cancer Biotherapy and Radiopharmaceuticals

Published by: Mary Ann Liebert, Inc  

People

  1. Scheinberg
    Scheinberg
  2. Mcdevitt
    Mcdevitt
  3. Bradbury
    Bradbury
  4. Curcio
    Curcio
  5. Korontsvit
    Korontsvit
  6. Pandit-Taskar
    Pandit-Taskar
  7. Shah
    Shah
  8. Zanzonico
    Zanzonico

Groups

  1. Adult Leukemia (10)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
  3. Center for Hematologic Malignancies (10)
  4. Center for Molecular Imaging and Biotechnology (10)
  5. Department of Medicine (10)
  6. GSK Faculty (10)
  7. Hematologic Malignancies Research (10)
  8. Hematologic Malignancies, Division of (10)
  9. Molecular Pharmacology and Chemistry Program Faculty (10)
  10. Sloan Kettering Institute Faculty (10)
Search Within
  1. "David Scheinberg"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (2)
Groups
  1. Adult Leukemia (10)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
  3. Center for Hematologic Malignancies (10)
  4. Center for Molecular Imaging and Biotechnology (10)
  5. Department of Medicine (10)
  6. GSK Faculty (10)

More Groups

People
  1. David Scheinberg (10)
  2. Michael Mcdevitt (6)
  3. Joseph Jurcic (5)
  4. Chaitanya Divgi (3)
  5. Ronald Finn (3)
  6. Steven Larson (3)

More People

Years
  1. 2020 (1)
  2. 2008 (1)
  3. 2006 (2)
  4. 2004 (2)
  5. 2000 (3)
  6. 1998 (1)
Publishers
  1. Mary Ann Liebert, Inc (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A genomic profile of local immunity in the melanoma microenvironment following treatment with α particle-emitting ultrasmall silica nanoparticles
    Journal Article

    Urbanska, A. M.; Khanin, R.; Alidori, S.; Wong, S.; Mello, B. P.; Almeida, B. A.; Chen, F.; Ma, K.; Turker, M. Z.; Korontsvit, T.; more...
    Cancer Biotherapy and Radiopharmaceuticals (2020)

    Fulltext@MSK | Save
  • Modeling analysis for Ac-225 radioimmunotherapy of leukemia
    Meeting Abstract

    Sgouros, G.; Jurcic, J. G.; Cicic, D.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2008)

    Fulltext@MSK | Save
  • Relative biological effectiveness for efficacy and toxicity in leukemia patients of the alpha-particle emitter, bismuth-213
    Meeting Abstract

    Sgouros, G.; Bolch, W. E.; Shah, A.; Watchman, C. J.; Jurcic, J. G.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • Alpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225
    Meeting Abstract

    Jurcic, J. G.; McDevitt, M. R.; Pandit-Taskar, N.; Divgi, C. R.; Finn, R. D.; Sgouros, G.; Apostalidis, C.; Chanel, S.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • Multivesicular radioimmunoliposomes with encapsulated actinium-225 for targeted alpha-particle therapy of intraperitoneal micrometastatic cancer
    Meeting Abstract

    Sofou, S.; Enmon, R.; McDevitt, M. R.; Jaggi, J.; Thomas, J. L.; Scheinberg, D. A.; Sgouros, G.
    Cancer Biotherapy and Radiopharmaceuticals (2004)

    Fulltext@MSK | Save
  • Bismuth-labeled anti-CD33 antibody for elimination of minimal residual disease in acute myeloid leukemia
    Meeting Abstract

    Mulford, D.; Divgi, C.; Mcdevitt, M.; Sgouros, G.; Finn, R.; Larson, S.; Apostolidis, C.; Morgenstern, A.; Scheinberg, D.; Jurcic, J.
    Cancer Biotherapy and Radiopharmaceuticals (2004)

    Fulltext@MSK | Save
  • Yttrium-90 anti-CD19 radioimmunotherapy for lymphoma
    Meeting Abstract

    Ma, D.; Barendswaard, E.; McDevitt, M. R.; Lai, L.; Curcio, M. J.; Pellegrini, V.; Brechbiel, M. W.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2000)

    Fulltext@MSK | Save
  • Phase I trial of yttrium-90-HuM195 (anti-CD33) in myeloid leukemia: Potential for myeloablation
    Meeting Abstract

    Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Ma, D.; Sgouros, G.; Hamacher, K. A.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2000)

    Fulltext@MSK | Save
  • Cell surface receptor-targeted therapy of acute myeloid leukemia: A review
    Journal Article

    Frankel, A. E.; Sievers, E. L.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2000)

    Fulltext@MSK | Save
  • mAbs to the extracellular domain of prostate specific membrane antigen (PSMA)
    Meeting Abstract

    Liu, H.; Rajasekaran, A.; Scheinberg, D.; Sgouros, G.; Geerlings, M.; Vallabhajosula, S.; Hamilton, A.; King, S.; Carr, F.; Bander, N.
    Cancer Biotherapy and Radiopharmaceuticals (1998)

    Fulltext@MSK | Save

    • Cancer Biotherapy and Radiopharmaceuticals – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Biotherapy & Radiopharmaceuticals 1084-9785 Unknown
    Cancer Biotherapy and Radiopharmaceuticals 10849785 Unknown
    Cancer Biotherapy and Radiopharmaceuticals 10849785 Mary Ann Liebert, Inc
    Cancer Biotherapy and Radiopharmaceuticals 1084-9785 Mary Ann Liebert, Inc
    Cancer Biotherapy and Radiopharmaceuticals 1084-9785 Mary Ann Liebert, Inc
    Cancer Biotherapy and Radiopharmaceuticals 1084-9785 Mary Ann Liebert, Inc
    Cancer Biotherapy and Radiopharmaceuticals 10849785 Mary Ann Liebert, Inc
    Cancer Biotherapy and Radiopharmaceuticals 1084-9785 Unknown
    Cancer Biotherapy and Radiopharmaceuticals 1084-9785 Mary Ann Liebert, Inc